Copyright
©The Author(s) 2016.
World J Gastroenterol. Jul 14, 2016; 22(26): 5879-5887
Published online Jul 14, 2016. doi: 10.3748/wjg.v22.i26.5879
Published online Jul 14, 2016. doi: 10.3748/wjg.v22.i26.5879
Figure 2 Heterogeneity of HER2 expression in gastric and gastroesophageal cancer.
A: Gastric carcinoma, intestinal type, with HER2 overexpression (score 3+; left side) vs HER2 negativity (score 0, right side). Magnification 10 x; B: Gastroesophageal carcinoma with HER2 equivocal positivity (score 2+; left side) vs negativity (score 1+; right side). Magnification x 25.
- Citation: Grillo F, Fassan M, Sarocchi F, Fiocca R, Mastracci L. HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice. World J Gastroenterol 2016; 22(26): 5879-5887
- URL: https://www.wjgnet.com/1007-9327/full/v22/i26/5879.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i26.5879